Market Overview:
The global biopsy device market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cancer, technological advancements in biopsy devices, and rising demand for minimally invasive procedures. Based on type, the global biopsy device market is segmented into guidance system, needles, guns, reagents and kits, and others. The guidance system segment is expected to grow at a CAGR of 7.1% from 2018 to 2030 due to its ability to provide accurate results with minimal damage caused during the procedure. Based on application, the global biopsy device market is segmented into hospital, specialised oncology centres, diagnostic centres,, research institutes,. The hospital segment accounted for the largest share of the global biopsy device market in 2017 owingtothe increasing number of cancer patients requiring diagnosis and treatment.
Product Definition:
A biopsy device is a medical instrument used to obtain a tissue sample from a patient for diagnostic purposes. The importance of biopsy devices lies in their ability to provide accurate and timely diagnosis of diseases.
Guidance System:
The global guidance system market size was valued at USD 1.1 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of cancer, technological advancements, and demand for minimally invasive surgeries are some major factors that will drive growth during the forecast period.
Needles:
The Needles and its usage in the biopsy device market is used by medical practitioners to remove a small sample of tissue from the body for examination under a microscope. The needles are thin, hollow tubes made up of metal or plastic that has been sharpened at one end. It is inserted into the skin through injection sites and then extracted back out through another site to obtain samples for testing or injecting drugs.
Application Insights:
The hospital application segment dominated the global biopsy device market in 2017. The growing prevalence of cancer and increasing number of patients suffering from various cancers are the major factors contributing to the large share held by this segment. According to WHO, around 1 in 6 people dies due to cancer and it is estimated that around 2 million people die due to this disease every year globally. Thus, a significant number of patients suffer from late diagnosis which requires accurate pre-operative diagnosis for an appropriate surgical treatment planning leading to an increased demand for biopsy devices used in hospitals across the world.
Specialized oncology centers accounted for a substantial share owing to their focus on providing better care with respect both diagnostics as well as treatment options offered by these centers compared with general hospitals or clinics where such devices can be used at lower costs or even not at all cost depending upon patient¢â‚¬â„¢s insurance coverage.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as local presence of major players, high adoption rate of advanced technologies, and increasing healthcare expenditure in the region. In addition, rising prevalence of cancer is also expected to drive regional growth over the forecast period. Asia Pacific is estimated to witness lucrative growth during the same period owing to improving healthcare infrastructure and growing awareness about early diagnosis among patients as well as physicians.
Major companies include but are not limited with Abbott; Beckman Coulter; Becton Dickinson & Company; Fujifilm Wako Pure Chemical Corp.; GE Healthcare; Koninklijke Philips N.V.; Merck KGaA Darmstadt GmbH & Co.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the biopsy device market. According to the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths due to cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large demand for biopsy devices as they are used for diagnosing various types of cancers.
- Technological advancements: The technological advancements in the field of medical devices are another key growth driver for the biopsy device market. With continuous innovations, manufacturers are able to develop better and more efficient devices that can provide accurate results with less pain and trauma inflicted on patients undergoing a biopsy procedure.
Scope Of The Report
Report Attributes
Report Details
Report Title
Biopsy Device Market Research Report
By Type
Guidance System, Needles, Guns, Reagents and Kits, Others
By Application
Hospital, Specialised Oncology Centres, Diagnostic Centres, Research Institutes
By Companies
Becton, Dickinson and Company, Argon Medical, B. Braun Melsungen AG, Boston Scientific, C. R. Bard, Hologic, Cook Medical, INRAD, Devicor Medical Products, PLANMED OY, Becton, Dickinson and Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Biopsy Device Market Report Segments:
The global Biopsy Device market is segmented on the basis of:
Types
Guidance System, Needles, Guns, Reagents and Kits, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Specialised Oncology Centres, Diagnostic Centres, Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton, Dickinson and Company
- Argon Medical
- B. Braun Melsungen AG
- Boston Scientific
- C. R. Bard
- Hologic
- Cook Medical
- INRAD
- Devicor Medical Products
- PLANMED OY
- Becton, Dickinson and Company
Highlights of The Biopsy Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Guidance System
- Needles
- Guns
- Reagents and Kits
- Others
- By Application:
- Hospital
- Specialised Oncology Centres
- Diagnostic Centres
- Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Biopsy Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A biopsy device is a medical instrument used to remove tissue from a patient for examination.
Some of the key players operating in the biopsy device market are Becton, Dickinson and Company, Argon Medical, B. Braun Melsungen AG, Boston Scientific, C. R. Bard, Hologic, Cook Medical, INRAD, Devicor Medical Products, PLANMED OY, Becton, Dickinson and Company.
The biopsy device market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Biopsy Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Biopsy Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Biopsy Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Biopsy Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Biopsy Device Market Size & Forecast, 2020-2028
4.5.1 Biopsy Device Market Size and Y-o-Y Growth
4.5.2 Biopsy Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Guidance System
5.2.2 Needles
5.2.3 Guns
5.2.4 Reagents and Kits
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Specialised Oncology Centres
6.2.3 Diagnostic Centres
6.2.4 Research Institutes
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Biopsy Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Biopsy Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Guidance System
9.6.2 Needles
9.6.3 Guns
9.6.4 Reagents and Kits
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Specialised Oncology Centres
9.10.3 Diagnostic Centres
9.10.4 Research Institutes
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Guidance System
10.6.2 Needles
10.6.3 Guns
10.6.4 Reagents and Kits
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Specialised Oncology Centres
10.10.3 Diagnostic Centres
10.10.4 Research Institutes
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Guidance System
11.6.2 Needles
11.6.3 Guns
11.6.4 Reagents and Kits
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Specialised Oncology Centres
11.10.3 Diagnostic Centres
11.10.4 Research Institutes
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Guidance System
12.6.2 Needles
12.6.3 Guns
12.6.4 Reagents and Kits
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Specialised Oncology Centres
12.10.3 Diagnostic Centres
12.10.4 Research Institutes
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Guidance System
13.6.2 Needles
13.6.3 Guns
13.6.4 Reagents and Kits
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Specialised Oncology Centres
13.10.3 Diagnostic Centres
13.10.4 Research Institutes
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Biopsy Device Market: Competitive Dashboard
14.2 Global Biopsy Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton, Dickinson and Company
14.3.2 Argon Medical
14.3.3 B. Braun Melsungen AG
14.3.4 Boston Scientific
14.3.5 C. R. Bard
14.3.6 Hologic
14.3.7 Cook Medical
14.3.8 INRAD
14.3.9 Devicor Medical Products
14.3.10 PLANMED OY
14.3.11 Becton, Dickinson and Company
